Introduction of diabetic nephropathy
出自KMU Wiki
(修訂版本間差異)
| 在2018年3月13日 (二) 17:10所做的修訂版本 (編輯) Guhjy (對話 | 貢獻) ←上一個 |
在2018年3月13日 (二) 17:14所做的修訂版本 (編輯) (撤銷) Guhjy (對話 | 貢獻) 下一個→ |
||
| 第6行： | 第6行： | ||
| **DCCT (Diabetes Control and Complications Trial) | **DCCT (Diabetes Control and Complications Trial) | ||
| ***Type 1 DM | ***Type 1 DM | ||
| - | ***NEJM 1993;329:977: | + | ***NEJM 1993;329:977: [The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus|http://content.nejm.org/cgi/content/short/329/14/977] |
| **UKPDS (UK Prospective Diabetes Study) | **UKPDS (UK Prospective Diabetes Study) | ||
| ***Type 2 DM | ***Type 2 DM | ||
| **Effects on macroangiopathy (cardiovascular disease and atherosclerosis) are less certain | **Effects on macroangiopathy (cardiovascular disease and atherosclerosis) are less certain | ||
在2018年3月13日 (二) 17:14所做的修訂版本
- The most common cause of incident ESRD and the 2nd commonest cause of prevalent ESRD in Taiwan
- Prevalence
- 40% in type 1 and 2 DM
- Because type 2 DM is much more common than type 1 DM, most diabetic nephropathy patients have type 2 DM
- Importance of hyperglycemia in DN
- DCCT (Diabetes Control and Complications Trial)
- Type 1 DM
- NEJM 1993;329:977: [The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus|http://content.nejm.org/cgi/content/short/329/14/977]
- UKPDS (UK Prospective Diabetes Study)
- Type 2 DM
- Effects on macroangiopathy (cardiovascular disease and atherosclerosis) are less certain
- DCCT (Diabetes Control and Complications Trial)
